Stock KIMIABL KIMIA BIOSCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Kimia Biosciences Limited

Equities

KIMIABL

INE285U01025

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:58 2024-06-19 am EDT 		5-day change 1st Jan Change
54 INR +0.28% Intraday chart for Kimia Biosciences Limited -1.28% +46.74%
Jun. 14 Kimia Biosciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Jun. 14 Kimia Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Business Summary

Kimia Biosciences Limited is an India-based company, which is engaged in the business of pharmaceutical products. The Company provides its products under various categories: Commercial Active Pharmaceutical Ingredients (APIs), Commercial KSMs, Intermediates & Reagents. The Company's Commercial-APIs products include acotiamide hydrochloride hydrate, azelnidipine, benfotiamine, benidipine hydrochloride, citicoline sodium, gliclazide, dapagliflozin propanediol monohydrate, levosulpiride, luliconazole, oxaceprol, prucalopride succinate, teneligliptin hydrobromide hydrate, vildagliptin, fimasartan trihydrate potassium, obeticholic acid and ursodeoxycholic acid. Its Commercial KSMs, Intermediates & Reagents products include Ethyl-2-Amino 1,3-Thiazole 4-Carboxylate, 2,4,5-Trimethoxy Benzoic Acid, Ethyl 2-(2,4,5-trimethoxybenzamido)-1,3-thiazole-4-carboxylate, Isopropyl 2-(3-Nitrobenzylidene) Acetoacetate, Choline phosphate chloride calcium, and more.

Number of employees: 241

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
1,246 99.8 % 1,285 100.0 % +3.12%

Sales per region

INR in Million2022Weight2023Weight Delta
India
80.7 %
1,019 81.7 % 1,034 80.7 % +1.49%
International
19.3 %
227 18.3 % 247 19.3 % +8.76%

Managers

Managers TitleAgeSince
Sameer Goel CEO
 Chief Executive Officer 49 16-03-28
Rakesh Chetani DFI
 Director of Finance/CFO - 23-09-06
Lakshay Prakash CMP
 Compliance Officer - 22-05-15
Jatin Sharma LAW
 General Counsel 37 23-01-04
Ruchita Gopal Mishra SAM
 Sales & Marketing 34 21-06-27
Bhalerao Asit Tanaji HRO
 Human Resources Officer 42 21-11-10
Ravi Kumar PRN
 Corporate Officer/Principal 50 19-07-03
Mukesh Kumar Sharma PRN
 Corporate Officer/Principal 57 17-12-03

Members of the board

Members of the board TitleAgeSince
Sameer Goel CEO
 Chief Executive Officer 49 16-03-28
Jagdeep Dhawan BRD
 Director/Board Member 53 16-03-28
Richa Gupta BRD
 Director/Board Member 43 16-04-14
Vipul Goel BRD
 Director/Board Member 46 19-10-06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 47,312,741 3,704,067 ( 7.829 %) 0 7.829 %

Company contact information

Kimia Biosciences Ltd.

974, Aggarwal Millennium, Tower-II Netaji Subhash Place, Pitampura

110034, New Delhi

+91 11 4706 3600

http://www.kimiabiosciences.com
address Kimia Biosciences Limited(KIMIABL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
KIMIA BIOSCIENCES LIMITED Stock Kimia Biosciences Limited
+46.74% 30.56M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+52.93% 803B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.98% 629B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.08% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.40% 324B
ABBVIE INC. Stock AbbVie Inc.
+10.58% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.42% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+2.17% 226B
NOVARTIS AG Stock Novartis AG
+10.66% 215B
AMGEN INC. Stock Amgen Inc.
+6.24% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. KIMIABL Stock
  4. Company Kimia Biosciences Limited